Tag: Endospan
Endospan announces positive 30-day outcomes from TRIOMPHE IDE study
Endospan recently announced the presentation of 30-day results from the statistical dissection primary arm of the TRIOMPHE investigational device exemption (IDE) clinical study. The...
Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study
Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic...
Endospan releases early TRIOMPHE IDE study results at Society of Thoracic...
Endospan shared 30-day results from the first 22 patients enrolled in the TRIOMPHE investigational device exemption (IDE) study in a late-breaking presentation at the...
FDA grants Nexus aortic arch stent graft system breakthrough designation
Endospan was recently granted breakthrough device designation from the Food and Drug Administration (FDA) for the Nexus aortic arch stent graft system.
The FDA’s breakthrough...